Back to top

If you wish to go to ZacksFunds.com, click OK. If you do not, click Cancel.

MARKET VECTORS BIOTECH ETF: (BBH)

(Real Time Quote from BATS) As of Dec 29, 2014 10:58 AM ET

 Add to portfolio

$116.42 USD

116.42
113,894

-0.18 (-0.15%)

Volume: 113,894

Zacks ETF Rank: 1 - Strong Buy [?] 1        

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

ETF Quote Details

Previous Close 116.60
Open 114.83
Bid 116.52
Ask 116.62
Day Low-High 115.97-117.70
52wk Low-High 80.05-122.87
Volume 113,894
NAV (month end) 117.14
Premium (+)/Discount (-) (month end)-0.54

Zacks Premium Research for BBH

Zacks ETF Rank [?] Strong Buy 1
ETF Risk [?] High
ETF Research Report

Zacks proprietary quantitative models divide each set of ETFs following a similar investment strategy (style box/industry/asset class) into three risk categories- High, Medium, and Low. The aim of our models is to select the best ETFs within each risk category, so that investors can pick an ETF that matches their particular risk preference in order to better achieve their investment goals.

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

ETF Expense Ratio

Expense Ratio 0.35%
Dividend (Yield) $0.00 (0.00%)
Issuer VAN ECK

Benchmark for BBH

MARKET VECTORS US LISTED BIOTECH 25 INDE

This benchmark index is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded biotech companies.

Fund Summary for BBH

MARKET VECTORS BIOTECH ETF

The Market Vectors Biotech ETF seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Market Vectors US Listed Biotech 25 Index. The Index is a rules based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded biotech companies.